MIGUEL MORENO
MIGUEL MORENO
Miguel Moreno received his Ph.D. in 2005 at the University of Alcala de Henares where he developed electrochemical DNA biosensors based on DNA-gold capped nanoparticles. As part of his Master degree, he selected aptamers against a protein of Leishmania infantum. In 2003 he joined the group of Prof. Carlos Martinez A. (CNB-CSIC) to develop DNA arrays based on nanocantilevers in close collaboration with the group of Prof. Laura Lechuga (IMM-CNM-CSIC). In 2006 he moved to Prof. David Russell’s group at the University of East Anglia (UK) where he was involved in the development of gold nanoparticles as drug carriers for in vivo PDT. In 2007 he co-founded Bioapter, a novel technological company based on the development of aptamers based biosensors and therapies. In October 2009 he joined the group of Carlos Briones at the Astrobiology Centre in Madrid where he has been exploring the origin of life through the development of aptamers against virus and small molecules as biomarkers of extinct life, as well as developing new nanotechlogies applied to the study of nucleic acids structure. In 2019 he has joined APTUS Biotech as CSO, where he is managing preclinical trials of anti-tumoral aptamers developed by the company.
33 Trabajos publicados
Compañías
APTUS BIOTECH
No se ha especificado una descripción o un objeto social para esta compañía.
Universidad
APTUS BIOTECH.
33 Trabajos publicados
Attomolar detection of hepatitis C virus core protein powered by molecular antenna-like graphene effect.
Tecnologías
Este investigador todavia no tiene tecnologías de sus trabajos
Perfil de ORCID
0000-0002-6065-4095